DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Zijlstra E, Demissie M, Graungaard T. et al.
Compatibility and safety of faster-acting insulin aspart used in continuous subcutaneous insulin therapy in patients with type 1 diabetes.
Boston, MA, USA:
The Endocrine Society´s 98th Annual Meeting and Expo. . 1–4 April 2016: Poster number FRI-69
We do not assume any responsibility for the contents of the web pages of other providers.